# Assessing the Impact of Control-IQ Technology

> **NCT04838561** · — · COMPLETED · sponsor: **Children's Hospital of Eastern Ontario** · enrollment: 65 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04838561
- **Lead sponsor:** Children's Hospital of Eastern Ontario
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2021-10-26
- **Final completion:** 2021-10-26
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2022-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838561, "Assessing the Impact of Control-IQ Technology". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04838561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*